Cancer CouncilGo to cancer.org.au
Clinical Guidelines.
Home

Clinical Guidelines Sitemap

  • About
    • About clinical guidelines
    • Disclosure of interests
  • Guidelines
    • Browse all guidelines
      • Adolescents and young adults (AYA)
      • Bowel cancer
      • Cancer pain management
      • Cancer therapy medication safety
      • Cervical cancer
      • Endometrial cancer
      • Fertility preservation for people with cancer
      • Head and neck cancer
      • Liver cancer
      • Lung cancer
      • Management of communication and swallowing
      • Neuroendocrine neoplasms (NENs)
      • Oesophageal cancer
      • Prostate cancer
      • Skin cancer
      • Teleoncology
    • Archived guidelines
  • Cervical cancer
    • Cervical cancer screening
      • Table of Contents
      • Foreword
      • Introduction
      • Summary of recommendations
      • 1. Cervical cancer in Australia
      • 2. The rationale for primary HPV screening
      • 3. Terminology
      • 4. Unsatisfactory cervical screening results
      • 5. Benefits, harms and cost-effectiveness in renewed National Cervical Screening Program (NCSP)
      • 6. Management of oncogenic HPV test results
      • 7. Colposcopy
      • 8. Management of discordant colposcopic impression, histopathology and referral LBC prediction
      • 9. Management of histologically confirmed low-grade squamous abnormalities
      • 10. Management of histologically confirmed high-grade squamous abnormalities
      • 11. Management of glandular abnormalities
      • 12. HPV screening strategies for Aboriginal and Torres Strait Islander women
      • 13. Screening after total hysterectomy
      • 14. Screening in pregnancy
      • 15. Women experienced early sexual activity or victims of abuse
      • 16. Screening in immune-deficient women
      • 17. DES-exposed women
      • 18. Signs and symptoms of cervical cancer
      • 19. Psychosocial care
      • 20. Transition to the renewed National Cervical Screening Program
      • Appendices
  • Fertility preservation for people with cancer
    • Summary of recommendations
    • Impact on fertility
      • Pregnancy and live birth
      • Ovarian function
      • Testicular function
    • Discussing Risk
      • Reproductive concerns
      • Health professional awareness
      • Role of oncology services
    • Referral and service provision
      • Referral rates
      • Referral pathways
      • Service provision
    • Psychological support
      • Fertility counselling
      • Decision making
    • Options for treatment
      • Sperm cryopreservation
      • Testicular biopsy
      • Embryo cryopreservation
      • Oocyte cryopreservation
      • Ovarian stimulation
      • Ovarian tissue cryopreservation
      • Ovarian transposition
      • Ovarian suppression
    • Pubertal development
    • Contraception
      • During treatment
      • After treatment
    • Conception
      • Interrupting therapy
      • Assisted reproduction
    • Pregnancy
      • Pregnancy of recurrence
      • Risk of complications
    • Appendices
      • Guideline development process
      • Working Group
      • Additional resources
  • Clinical Guidelines
    • A code of practice for declaring and dealing with competing interests
    • About Cancer Council’s Clinical Practice Guidelines
    • Adolescents and young adults (AYA) cancer clinical guidelines
      • Early detection of cancer in AYAs
      • Psychosocial management of AYAs diagnosed with cancer: Guidance for health professionals
    • Clinical practice guidelines for teleoncology
    • Oesophageal cancer clinical guidelines
      • Clinical practice guidelines for the diagnosis and management of Barrett’s oesophagus and early oesophageal adenocarcinoma
    • Bowel cancer clinical guidelines
      • Clinical practice guidelines for the prevention, early detection and management of colorectal cancer
      • Clinical practice guidelines for surveillance colonoscopy
    • COSA guidelines for the safe prescribing, dispensing and administration of systemic cancer therapy
    • Cervical cancer clinical guidelines
      • National cervical screening program
        • Appendices
          • Appendix B
          • Appendix C
          • Appendix D
          • Appendix E
          • Appendix F
          • Appendix G
          • Appendix H
          • Appendix J
          • Appendix I
          • Appendix A
        • Foreword
        • 17. DES-exposed women
        • Introduction
        • 10. Management of histologically confirmed high-grade squamous abnormalities
          • Diagnosis of high-grade squamous abnormalities
          • Management of histologically confirmed high-grade squamous abnormalities
          • Test of Cure after treatment for HSIL (CIN2/3)
          • Treatment of high-grade squamous abnormalities
        • 11. Management of glandular abnormalities
          • Management of histologically confirmed high-grade glandular abnormalities
          • Follow-up after excisional treatment for AIS
          • Investigation of cytological glandular abnormalities
        • 12. HPV screening strategies for Aboriginal and Torres Strait Islander women
        • 13. Screening after total hysterectomy
        • 14. Screening in pregnancy
        • 15. Women experienced early sexual activity or victims of abuse
        • 16. Screening in immune-deficient women
        • 18. Signs and symptoms of cervical cancer
          • Investigations of other symptoms: vaginal discharge and deep dyspareunia
          • Investigation of abnormal vaginal bleeding
        • 19. Psychosocial care
        • 1. Cervical cancer in Australia
        • 20. Transition to the renewed National Cervical Screening Program
        • 3. Terminology
          • Cytology and AMBS 2004 terminology for reporting
          • Histopathology
          • HPV testing terminology
          • Preparation of cervical screening reports
          • Supplement: Sample reports
        • 4. Unsatisfactory cervical screening results
        • 5. Benefits, harms and cost-effectiveness in renewed National Cervical Screening Program (NCSP)
        • 6. Management of oncogenic HPV test results
          • Management of HPV test results
          • Medical Services Advisory Committee recommendations for HPV testing
          • Oncogenic HPV types not 16/18
          • Oncogenic HPV types 16 and/or 18
          • Oncogenic HPV types not detected
          • Screening in women older than 75
          • Self-collected vaginal samples
          • Flowcharts: Management of oncogenic HPV test results
          • Women undergoing exit testing
        • 7. Colposcopy
          • Colposcopy data for the National Cancer Screening Register
          • Colposcopy terminology
          • History, examination and investigation
          • Principles of practice
          • Quality improvement in colposcopy
          • Supplement. Colposcopy information for discussion with patient
          • Supplement. Colposcopy technologies and documentation
          • Colposcopy and treatment
        • 8. Management of discordant colposcopic impression, histopathology and referral LBC prediction
          • Management of discordant colposcopic impression, histopathology and referral LBC prediction
          • Normal colposcopic findings following LBC prediction of Negative, LSIL or HSIL
          • Type 3 TZ (previously termed ‘unsatisfactory’) colposcopy following LBC prediction of Negative, LSIL or HSIL
        • 9. Management of histologically confirmed low-grade squamous abnormalities
        • Table of Contents
        • 2. The rationale for primary HPV screening
        • Summary of recommendations
    • Clinical practice guidelines for the treatment and management of endometrial cancer
    • Browse all clinical guidelines
      • Early detection of cancer in AYA
    • Lung cancer clinical guidelines
      • Clinical practice guidelines for the treatment of lung cancer
      • Clinical practice guidelines for the prevention and diagnosis of lung cancer
    • Clinical practice guideline for the management of communication and swallowing in children diagnosed with childhood brain tumour or leukaemia
    • Cancer pain management in adults clinical guidelines
    • Prostate cancer clinical guidelines
      • Clinical practice guidelines for PSA testing and early management of test-detected prostate cancer
    • Skin cancer clinical guidelines
      • Clinical practice guidelines for keratinocyte cancer
      • Clinical practice guidelines for the diagnosis and management of melanoma
    • Archive of clinical guidelines and resources
    • COSA guidelines for fertility preservation for people with cancer
      • Appendices
        • Additional resources
        • COSA Fertility Preservation Guidelines Working Group
        • Guideline development process
      • Contraception
        • Contraception after cancer treatment
        • Cancer Fertility Preservation
      • Discussing Risk
        • Reproductive concerns
        • Health professional awareness
        • Role of oncology services
      • Impact on fertility
        • Pregnancy and live birth
        • Ovarian function
        • Testicular function
      • Pubertal development
      • Pregnancy
        • Pregnancy and risk of cancer recurrence
        • Risk of pregnancy complications
      • Psychological support
        • Decision making
        • Fertility counselling
      • Referral and service provision
        • Oncofertility service provision
        • Referral rates and decisional conflict
        • Referral pathways
      • Summary of recommendations
      • Options for treatment
        • Embryo cryopreservation
        • Oocyte cryopreservation
        • Safety of ovarian stimulation
        • Ovarian suppression with GnRH analogues
        • Ovarian tissue cryopreservation
        • Ovarian transposition
        • Sperm cryopreservation
        • Testicular biopsy
      • Conception
        • Assisted reproduction and risk of cancer recurrence
        • Interrupting hormone therapy to conceive
    • Evidence-based practice guidelines for the nutritional management of adult patients with head and neck cancer
    • Liver cancer clinical guidelines
      • Clinical practice guidelines for hepatocellular carcinoma surveillance for people at high risk in Australia
    • Neuroendocrine neoplasms (NENs) consensus guidelines
Clinical Guidelines Sitemap
About guidelinesArchived guidelinesDisclosure of interests National Cancer Prevention Policy
Privacy PolicyAccessibilityDisclaimerSitemap